Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-379
Closed -$2.06K 267
2024
Q2
$2.06K Hold
379
﹤0.01% 259
2024
Q1
$2.46K Hold
379
﹤0.01% 190
2023
Q4
$2.89K Hold
379
﹤0.01% 202
2023
Q3
$2.26K Hold
379
﹤0.01% 209
2023
Q2
$4.63K Buy
+379
New +$5.01K ﹤0.01% 204
2022
Q4
Sell
-103
Closed -$9K 238
2022
Q3
$9K Hold
103
﹤0.01% 183
2022
Q2
$15K Hold
103
0.01% 158
2022
Q1
$16K Buy
+103
New +$22.9K ﹤0.01% 159

Other funds holding NEUE

Gleason Group's NEUE Position: Q3 2024 in Review

Gleason Group sold out of NeueHealth (NEUE) in Q3 2024, closing a stake of 379 shares — an estimated $2.06K sold.

Gleason Group first reported a position in NEUE in Q1 2022 and held it in 8 quarters. The position peaked at $16K in Q1 2022. 36 funds tracked by Wall St. Rank hold NEUE as of Q3 2024.

  • Gleason Group reported no remaining NeueHealth position as of Q3 2024 after selling out during the quarter.
  • Gleason Group sold 379 NeueHealth shares in Q3 2024, an estimated $2.06K.
  • Gleason Group first reported a position in NeueHealth in Q1 2022 and held it in 8 quarters.
  • Gleason Group's NeueHealth position peaked at $16K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held NeueHealth as of Q3 2024.

Based on Gleason Group's 13F filing for Q3 2024, filed 15 Oct 2024.